CENTRALE DEL LATTE D'ITALIA (CLI.MI) Fundamental Analysis & Valuation

BIT:CLI • IT0003023980

4.4 EUR
0 (0%)
Last: Mar 10, 2026, 07:00 PM

This CLI.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CLI. CLI was compared to 64 industry peers in the Food Products industry. There are concerns on the financial health of CLI while its profitability can be described as average. CLI may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

6

1. CLI.MI Profitability Analysis

1.1 Basic Checks

  • In the past year CLI was profitable.
  • CLI had a positive operating cash flow in the past year.
  • Each year in the past 5 years CLI has been profitable.
  • Each year in the past 5 years CLI had a positive operating cash flow.
CLI.MI Yearly Net Income VS EBIT VS OCF VS FCFCLI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

  • CLI has a Return On Assets (3.87%) which is in line with its industry peers.
  • The Return On Equity of CLI (14.51%) is better than 78.13% of its industry peers.
  • CLI has a better Return On Invested Capital (10.93%) than 87.50% of its industry peers.
  • CLI had an Average Return On Invested Capital over the past 3 years of 4.02%. This is below the industry average of 7.07%.
  • The 3 year average ROIC (4.02%) for CLI is below the current ROIC(10.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.87%
ROE 14.51%
ROIC 10.93%
ROA(3y)0.98%
ROA(5y)1.12%
ROE(3y)3.7%
ROE(5y)4.3%
ROIC(3y)4.02%
ROIC(5y)3.66%
CLI.MI Yearly ROA, ROE, ROICCLI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • CLI's Profit Margin of 1.91% is in line compared to the rest of the industry. CLI outperforms 46.88% of its industry peers.
  • In the last couple of years the Profit Margin of CLI has grown nicely.
  • CLI has a worse Operating Margin (3.48%) than 60.94% of its industry peers.
  • In the last couple of years the Operating Margin of CLI has grown nicely.
  • CLI has a Gross Margin of 19.91%. This is in the lower half of the industry: CLI underperforms 75.00% of its industry peers.
  • CLI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.48%
PM (TTM) 1.91%
GM 19.91%
OM growth 3Y15.43%
OM growth 5YN/A
PM growth 3Y16.01%
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5Y-14.6%
CLI.MI Yearly Profit, Operating, Gross MarginsCLI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. CLI.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLI is creating value.
  • The number of shares outstanding for CLI remains at a similar level compared to 1 year ago.
  • CLI has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CLI is higher compared to a year ago.
CLI.MI Yearly Shares OutstandingCLI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CLI.MI Yearly Total Debt VS Total AssetsCLI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • CLI has an Altman-Z score of 2.58. This is not the best score and indicates that CLI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CLI has a Altman-Z score of 2.58. This is in the better half of the industry: CLI outperforms 67.19% of its industry peers.
  • The Debt to FCF ratio of CLI is 5.46, which is a neutral value as it means it would take CLI, 5.46 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.46, CLI is in the better half of the industry, outperforming 67.19% of the companies in the same industry.
  • CLI has a Debt/Equity ratio of 0.56. This is a neutral value indicating CLI is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.56, CLI is in line with its industry, outperforming 54.69% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 5.46
Altman-Z 2.58
ROIC/WACC2.14
WACC5.1%
CLI.MI Yearly LT Debt VS Equity VS FCFCLI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 0.86 indicates that CLI may have some problems paying its short term obligations.
  • CLI has a Current ratio of 0.86. This is in the lower half of the industry: CLI underperforms 76.56% of its industry peers.
  • A Quick Ratio of 0.69 indicates that CLI may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.69, CLI is doing worse than 64.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.69
CLI.MI Yearly Current Assets VS Current LiabilitesCLI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

5

3. CLI.MI Growth Analysis

3.1 Past

  • CLI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.22%, which is quite good.
  • Measured over the past years, CLI shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.63% on average per year.
  • Looking at the last year, CLI shows a small growth in Revenue. The Revenue has grown by 5.99% in the last year.
  • Measured over the past years, CLI shows a quite strong growth in Revenue. The Revenue has been growing by 14.83% on average per year.
EPS 1Y (TTM)15.22%
EPS 3Y24.63%
EPS 5YN/A
EPS Q2Q%-3.29%
Revenue 1Y (TTM)5.99%
Revenue growth 3Y7.26%
Revenue growth 5Y14.83%
Sales Q2Q%3.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.31% on average over the next years. This is quite good.
  • CLI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.36% yearly.
EPS Next Y-2.22%
EPS Next 2Y15.47%
EPS Next 3Y15.31%
EPS Next 5YN/A
Revenue Next Year8.24%
Revenue Next 2Y4.56%
Revenue Next 3Y3.36%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLI.MI Yearly Revenue VS EstimatesCLI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CLI.MI Yearly EPS VS EstimatesCLI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

8

4. CLI.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 6.11 indicates a rather cheap valuation of CLI.
  • CLI's Price/Earnings ratio is rather cheap when compared to the industry. CLI is cheaper than 95.31% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.71, CLI is valued rather cheaply.
  • A Price/Forward Earnings ratio of 7.26 indicates a rather cheap valuation of CLI.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CLI indicates a rather cheap valuation: CLI is cheaper than 90.63% of the companies listed in the same industry.
  • CLI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.82.
Industry RankSector Rank
PE 6.11
Fwd PE 7.26
CLI.MI Price Earnings VS Forward Price EarningsCLI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • CLI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CLI is cheaper than 98.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.04
EV/EBITDA 2.84
CLI.MI Per share dataCLI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The decent profitability rating of CLI may justify a higher PE ratio.
  • A more expensive valuation may be justified as CLI's earnings are expected to grow with 15.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.47%
EPS Next 3Y15.31%

0

5. CLI.MI Dividend Analysis

5.1 Amount

  • No dividends for CLI!.
Industry RankSector Rank
Dividend Yield 0%

CLI.MI Fundamentals: All Metrics, Ratios and Statistics

CENTRALE DEL LATTE D'ITALIA

BIT:CLI (3/10/2026, 7:00:00 PM)

4.4

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap61.60M
Revenue(TTM)522.24M
Net Income(TTM)9.99M
Analysts80
Price Target6.12 (39.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.11
Fwd PE 7.26
P/S 0.12
P/FCF 4.04
P/OCF 3.65
P/B 0.89
P/tB 1.25
EV/EBITDA 2.84
EPS(TTM)0.72
EY16.36%
EPS(NY)0.61
Fwd EY13.77%
FCF(TTM)1.09
FCFY24.75%
OCF(TTM)1.21
OCFY27.39%
SpS37.3
BVpS4.92
TBVpS3.53
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.93
Profitability
Industry RankSector Rank
ROA 3.87%
ROE 14.51%
ROCE 15.51%
ROIC 10.93%
ROICexc 17.78%
ROICexgc 24.39%
OM 3.48%
PM (TTM) 1.91%
GM 19.91%
FCFM 2.92%
ROA(3y)0.98%
ROA(5y)1.12%
ROE(3y)3.7%
ROE(5y)4.3%
ROIC(3y)4.02%
ROIC(5y)3.66%
ROICexc(3y)6.06%
ROICexc(5y)5.59%
ROICexgc(3y)8.01%
ROICexgc(5y)7.3%
ROCE(3y)5.7%
ROCE(5y)5.19%
ROICexgc growth 3Y32.21%
ROICexgc growth 5YN/A
ROICexc growth 3Y30.06%
ROICexc growth 5YN/A
OM growth 3Y15.43%
OM growth 5YN/A
PM growth 3Y16.01%
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5Y-14.6%
F-Score7
Asset Turnover2.02
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 5.46
Debt/EBITDA 1.12
Cap/Depr 10.1%
Cap/Sales 0.31%
Interest Coverage 5.37
Cash Conversion 49.27%
Profit Quality 152.57%
Current Ratio 0.86
Quick Ratio 0.69
Altman-Z 2.58
F-Score7
WACC5.1%
ROIC/WACC2.14
Cap/Depr(3y)17.55%
Cap/Depr(5y)36.42%
Cap/Sales(3y)0.86%
Cap/Sales(5y)2.07%
Profit Quality(3y)1366.96%
Profit Quality(5y)1110.01%
High Growth Momentum
Growth
EPS 1Y (TTM)15.22%
EPS 3Y24.63%
EPS 5YN/A
EPS Q2Q%-3.29%
EPS Next Y-2.22%
EPS Next 2Y15.47%
EPS Next 3Y15.31%
EPS Next 5YN/A
Revenue 1Y (TTM)5.99%
Revenue growth 3Y7.26%
Revenue growth 5Y14.83%
Sales Q2Q%3.67%
Revenue Next Year8.24%
Revenue Next 2Y4.56%
Revenue Next 3Y3.36%
Revenue Next 5YN/A
EBIT growth 1Y1.62%
EBIT growth 3Y23.81%
EBIT growth 5YN/A
EBIT Next Year133.78%
EBIT Next 3Y38.93%
EBIT Next 5YN/A
FCF growth 1Y24.28%
FCF growth 3Y-17.37%
FCF growth 5YN/A
OCF growth 1Y17.37%
OCF growth 3Y-18.49%
OCF growth 5Y10.4%

CENTRALE DEL LATTE D'ITALIA / CLI.MI FAQ

What is the ChartMill fundamental rating of CENTRALE DEL LATTE D'ITALIA (CLI.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CLI.MI.


What is the valuation status of CENTRALE DEL LATTE D'ITALIA (CLI.MI) stock?

ChartMill assigns a valuation rating of 8 / 10 to CENTRALE DEL LATTE D'ITALIA (CLI.MI). This can be considered as Undervalued.


How profitable is CENTRALE DEL LATTE D'ITALIA (CLI.MI) stock?

CENTRALE DEL LATTE D'ITALIA (CLI.MI) has a profitability rating of 6 / 10.


What is the valuation of CENTRALE DEL LATTE D'ITALIA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CENTRALE DEL LATTE D'ITALIA (CLI.MI) is 6.11 and the Price/Book (PB) ratio is 0.89.


What is the earnings growth outlook for CENTRALE DEL LATTE D'ITALIA?

The Earnings per Share (EPS) of CENTRALE DEL LATTE D'ITALIA (CLI.MI) is expected to decline by -2.22% in the next year.